In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...
This analysis documented the continued high burden of medically attended respiratory syncytial virus (RSV)-associated acute ...
RSV prevention among children, including nirsevimab and the maternal RSVpreF vaccine, may be associated with a reduction in pediatric ICU utilization.